Seeman P, Corbett R, Nam D, Van Tol H H
Department of Pharmacology, University of Toronto, Ontario, Canada.
Jpn J Pharmacol. 1996 Jul;71(3):187-204. doi: 10.1254/jjp.71.187.
This review summarizes the amino acid sequences of the human dopamine and serotonin receptors and their human variants. The review also examines the receptor basis of the atypical antipsychotic drugs that elicit less parkinsonism than the typical antipsychotics. Because the dissociation constant of a drug varies with the radioligand, the dissociation constants of many neuroleptics are here summarized for the dopamine D2-, D4- and serotonin S2A-receptors using different radioligands. Radioligands of low solubility in the membrane (having low tissue/buffer partition) result in lower values for the neuroleptic dissociation constants, compared to radioligands of high membrane solubility. Such studies yield the intrinsic K value for a neuroleptic in the absence of a competing ligand. Clozapine, for example, has an intrinsic K value of 1.6 nM at the D4-receptor, in agreement with the value of 1.6 nM when directly measured with [3H]clozapine at D4. However, because clozapine competes with endogenous dopamine, the in vivo clozapine concentration to occupy 75% of the dopamine D4-receptors is derived to be approximately 13 nM. This agrees with the value of 12 to 20 nM in the plasma water (or spinal fluid) observed in treated patients. Moreover, in L-DOPA psychosis (in Parkinson's disease), the clozapine concentration for 75% blockade of D4 is predicted to be approximately 3 nM. This agrees with the value of approximately 1.2 nM observed by Meltzer et al. in plasma water (Neuropsychopharmacology, 12, 39-45 (1995)). This analysis supports the concept and practical value of the intrinsic K values. Some atypical neuroleptics (remoxipride, clozapine, perlapine, seroquel and melperone) have high intrinsic K values (ranging from 30 to 88 nM) at the D2-receptor, making them displaceable by high levels of endogenous dopamine in the caudate/putamen. In contrast, however, typical neuroleptics (i.e., those that typically cause parkinsonism) have intrinsic K values of 0.3 to 6 nM, making them less displaceable by endogenous dopamine. A relationship exists between the neuroleptic doses for rat catalepsy and the D2/D4 ratio of the intrinsic K values. Thus, the atypical neuroleptics appear to fall into two groups, those that bind loosely to D2 and those that are selective at D4.
本综述总结了人类多巴胺和5-羟色胺受体及其人类变体的氨基酸序列。该综述还研究了与典型抗精神病药物相比引发较少帕金森症的非典型抗精神病药物的受体基础。由于药物的解离常数随放射性配体而变化,本文使用不同的放射性配体总结了多种抗精神病药物对于多巴胺D2、D4受体和5-羟色胺S2A受体的解离常数。与膜溶解性高的放射性配体相比,膜溶解性低(组织/缓冲液分配系数低)的放射性配体导致抗精神病药物的解离常数较低。此类研究得出了在不存在竞争配体情况下抗精神病药物的内在K值。例如,氯氮平在D4受体处的内在K值为1.6 nM,这与用[3H]氯氮平直接在D4受体处测量得到的1.6 nM值一致。然而,由于氯氮平与内源性多巴胺竞争,体内占据75%多巴胺D4受体的氯氮平浓度约为13 nM。这与治疗患者血浆水(或脑脊液)中观察到的12至20 nM值相符。此外,在左旋多巴诱发的精神病(帕金森病中),预计氯氮平阻断75% D4受体的浓度约为3 nM。这与Meltzer等人在血浆水中观察到的约1.2 nM值相符(《神经精神药理学》,12卷,39 - 45页(1995年))。该分析支持了内在K值的概念和实用价值。一些非典型抗精神病药物(瑞莫必利、氯氮平、哌拉平、喹硫平和美哌隆)在D2受体处具有较高的内在K值(范围为30至88 nM),使得它们可被尾状核/壳核中高水平的内源性多巴胺置换。然而,相比之下,典型抗精神病药物(即那些通常会导致帕金森症的药物)的内在K值为0.3至6 nM,使得它们较不易被内源性多巴胺置换。抗精神病药物导致大鼠僵住症的剂量与内在K值的D2/D4比值之间存在关联。因此,非典型抗精神病药物似乎分为两组,即那些与D2受体结合松散的药物和那些对D4受体具有选择性的药物。